alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
| Exhibit 32.2 |
|--------------|

|   | 1. | The Periodic Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2. | The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
|--------|----|---------------------------------------------------------------------------------------------------------------------------------------------------------------|

| /s/ ANTHONY J. GALICI                                 |
|-------------------------------------------------------|
| Anthony J. Galici                                     |
| Vice President, Chief Financial Officer and Secretary |
| July 7, 2010                                          |
NOTE: This disposition is nonprecedential.



## United States Court of Appeals for the Federal Circuit

2008-7073

DANIEL G. ROSS,

Claimant-Appellant,

v.

ERIC K. SHINSEKI, Secretary of Veterans Affairs,

Respondent-Appellee.

Zachary M. Stolz , Chisholm, Chisholm & Kilpatri ck, of Washington, DC, argued

for claimant-appellant. With him on the brief was Robert V. Chisholm , of Providence,

Rhode Island.

Meredyth Cohen Havasy , Trial Attorney, Commercial Litigation Branch, Civil

Division, United States Depa rtment of Justice, of Washington, DC, argued for

respondent-appellee. With her on t he brief were Jeanne E. Davidson , Director, and

Todd M. Hughes , Deputy Director. Of counsel on th e brief were Michael J. Timinski

, Deputy Assistant General Co unsel, Jamie L. Mueller , and Martie S. Adelman , Attorneys,

Office of the General Counsel, United States Department of Vete rans Affairs, of

Washington, DC.

Appealed from: United States Cour t of Appeals for Veterans Claims

Chief Judge William P. Greene, Jr.NOTE: This disposition is nonprecedential.



## United States Court of Appeals for the Federal Circuit

2008-7073

DANIEL G. ROSS,

Claimant-Appellant,

v.

ERIC K. SHINSEKI, Secretary of Veterans Affairs,

Respondent-Appellee.



## Judgment

ON APPEAL from the United States Court of Appeals

for Veterans Claims

in CASE NO(S). 05-2286.

This CAUSE having been hear d and considered, it is

ORDERED and ADJUDGED:

Per Curiam (MAYER, LOURIE, and SCHALL Circuit Judges )

AFFIRMED . See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

DATED February 4, 2009 /s/ Jan Horbaly

Jan Horbaly, Clerk
EXHIBIT 35.4

CERTIFICATION
OF SUBSERVICER PURSUANT TO ITEM 1123 OF REGULATION AB

March 23, 2009

CIT Funding
Company, LLC
1 CIT Drive
Livingston, NJ 07039

| |     |                                                                         
| | --- | ------------------------------------------------------------------------
| | Re: | CIT Equipment Collateral
 2008-VT1 Receivable-Backed Notes (the Notes)

I, Gavan Goss,
the Chief Financial Officer, for the 12-month period ending December 31, 2008, of DFS-SPV L.L.C. as well as
Dell Financial Services L.L.C. (collectively, the Subservicer). DFS-SPV
L.L.C. and Dell Financial Services L.L.C. are the continuing entities resulting
from the statutory conversion of DFS-SPV L.P. and Dell Financial Services L.P.,
respectively, under the Delaware Revised Uniform Limited Partnership Act as of March 20, 2008. In my role as Chief Financial
Officer of the Subservicer, I hereby certify that:

A
review of the activities of the Subservicer during the period from January 1,
    2008 through December 31, 2008 (the Reporting Period) and of the
    performance of the Subservicer with respect to its subservicing activities
    set forth in the Receivables Purchase Agreement effective as of October 31,
    1998, as amended, between DFS-SPV L.L.C.  and CIT Financial USA, Inc. (the Agreement)
    with respect to equipment loan and lease receivables originated or purchased
    by Dell Financial Services L.L.C. for which the Subservicer acted as a servicer
    which asset-backed securities transactions were issued on or after January
    1, 2006 and included as part of the Notes, has been made under my supervision;
    and

To
the best of my knowledge, based on such review, the Subservicer has fulfilled
its obligations under the Agreement in all material respects throughout the Reporting
    Period, except as described on Appendix
    B to the Subservicers Report on Assessment of Compliance with Applicable
    Servicing Criteria Pursuant to Item 1122 of Regulation AB.

|               |                                    |  |                                |     |                                    | 
|-------------- | ---------------------------------- |  | ------------------------------ | --- | ---------------------------------- | 
|DFS-SPV L.L.C. |                                    |  | Dell Financial Services L.L.C. |    
|               |                                    |  |                                |     |                                    | 
|By:            | /s/
 Gavan Goss                    |  |                                | By: | /s/
 Gavan Goss                    | 
|               |                                    |  |                                |     |                                    | 
|               | Name:  Gavan
 Goss                 |  |                                |     | Name:  Gavan
 Goss                 | 
|               | Title:    Chief
 Financial Officer |  |                                |     | Title:    Chief
 Financial Officer | 

-59-

---
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Homeland Security

###### Federal Emergency Management Agency

          - [Internal Agency Docket No. FEMA-4723-DR; Docket ID FEMA-2023-0001]

# AGENCY:

Federal Emergency Management Agency, DHS.

# ACTION:

Notice.

# SUMMARY:

This notice amends the notice of a major disaster declaration for the State of New York (FEMA-4723-DR), dated July 22, 2023, and related determinations.

# DATES:

This amendment was issued August 3, 2023.

# FOR FURTHER INFORMATION CONTACT:

Dean Webster, Office of Response and Recovery, Federal Emergency Management Agency, 500 C Street  SW, Washington, DC 20472, (202) 646-2833.

# SUPPLEMENTARY INFORMATION:

The notice of a major disaster declaration for the State of New York is hereby amended to include the following area among those areas determined to have been adversely affected by the event declared a major disaster by the President in his declaration of July 22, 2023.

Franklin County for Public Assistance.

The following Catalog of Federal Domestic Assistance Numbers (CFDA) are to be used for reporting and drawing funds: 97.030, Community Disaster Loans; 97.031, Cora Brown Fund; 97.032, Crisis Counseling; 97.033, Disaster Legal Services; 97.034, Disaster Unemployment Assistance (DUA); 97.046, Fire Management Assistance Grant; 97.048, Disaster Housing Assistance to Individuals and Households In Presidentially Declared Disaster Areas; 97.049, Presidentially Declared Disaster Assistance—Disaster Housing Operations for Individuals and Households; 97.050 Presidentially Declared Disaster Assistance to Individuals and Households—Other Needs; 97.036, Disaster Grants—Public Assistance (Presidentially Declared Disasters); 97.039, Hazard Mitigation Grant.

Deanne Criswell,

Administrator, Federal Emergency Management Agency.

[FR Doc. 2023-21022 Filed 9-26-23; 8:45 am]

BILLING CODE 9111-23-P
IV 

110TH CONGRESS 

2D SESSION H. RES. 1439 

Expressing support for designation of the month of September 2009 as 

‘‘National Atrial Fibrillation Awareness Month’’ and supporting efforts 

to educate the public about atrial fibrillation. 

IN THE HOUSE OF REPRESENTATIVES 

SEPTEMBER 15, 2008 

Mr. RUPPERSBERGER (for himself, Ms. GRANGER, and Mr. GONZALEZ) submitted the following resolution; which was referred to the Committee on 

Energy and Commerce 

RESOLUTION 

Expressing support for designation of the month of September 2009 as ‘‘National Atrial Fibrillation Awareness 

Month’’ and supporting efforts to educate the public 

about atrial fibrillation. 

Whereas atrial fibrillation is a cardiac condition in which 

electrical pulses disrupt the regular beating of the atria 

in the heart, hampering the atria’s ability to fill the ventricles with blood, thus allowing blood to pool in the atria 

and form clots; 

Whereas atrial fibrillation is the most common cardiac malfunction and affects at least 2,200,000 people in the 

United States; 


jbell on PROD1PC69 with BILLS
2 

•HRES 1439 IH 

Whereas atrial fibrillation is associated with an increased 

long-term risk of stroke, heart failure, and all-cause mortality, especially among women; 

Whereas atrial fibrillation accounts for approximately onethird of hospitalizations for cardiac rhythm disturbances; 

Whereas according to the American Heart Association, 3 to 

5 percent of people in the United States age 65 and older 

are estimated to have atrial fibrillation; 

Whereas atrial fibrillation is recognized as a major contributor of strokes, with an estimated 15 to 20 percent of 

strokes occurring in people with the condition; 

Whereas it is estimated that atrial fibrillation costs $3,600 

per patient annually for a total cost burden in the United 

States of $15,700,000,000; 

Whereas obesity is an important risk factor of atrial fibrillation; 

Whereas better patient and health care provider education is 

needed for the timely recognition of atrial fibrillation 

symptoms; 

Whereas more research into effective treatments for atrial fibrillation is needed; and 

Whereas September 2009 is an appropriate month to observe 

‘‘National Atrial Fibrillation Awareness Month’’: Now, 

therefore, be it 

1 Resolved, That the House of Representatives— 

2 (1) supports the designation of a ‘‘National 

3 Atrial Fibrillation Awareness Month’’; 


jbell on PROD1PC69 with BILLS
3 

•HRES 1439 IH 

1 (2) supports ‘‘National Atrial Fibrillation 

2 Awareness Month’’ and efforts to educate people 

3 about atrial fibrillation; 

4 (3) recognizes the need for additional research 

5 into treatment for atrial fibrillation; and 

6 (4) encourages the people of the United States 

7 and interested groups to observe and support ‘‘Na8 tional Atrial Fibrillation Awareness Month’’ through 

9 appropriate programs and activities to promote pub10 lic awareness of atrial fibrillation and potential 

11 treatments for it. 

Æ 


jbell on PROD1PC69 with BILLS
### Michigan Supreme Court Lansing, Michigan

Marilyn Kelly,
Chief Justice

Michael F. Cavanag h
Elizabeth A. Weave r

Maura D. Corriga n Robert P. Young, Jr. Stephen J. Markma n Diane M. Hathaway,
J ustices

I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

_______________________________________ __ Clerk August 6, 2009

l0720 

# Order

August 6, 2009

138032 (49)

PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee,

v SC: 138032 COA: 281690 Wayne CC: 07-005498-FH CORTLAND ANTONIO MILLER, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the motion for r econsideration of this Court's April 28, 2009 order is considered, and it is DENIED, because it does not appear that the order was entered erroneously.
| (1) | the Annual Report on Form 10-K of China Media Inc. for the year ended June 30, 2011 (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of China Media Inc. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------------------------|

| Dated: September 28, 2011 |                                                           |
|---------------------------|----------------------------------------------------------------|
|                      | /s/Shuncheng Ma                                                |
|                      | Shuncheng Ma                                                   |
|                      | Chief Financial Officer                                        |
|                      | (Principal Financial Officer and Principal Accounting Officer) |
MEMORANDUM OPINION

No. 04-12-00543-CV

IN RE Paul and Margaret PACE

Original Mandamus Proceeding1

PER CURIAM

Sitting: Phylis J. Speedlin, Justice

Steven C. Hilbig, Justice

Marialyn Barnard, Justice

Delivered and Filed: October 10, 2012

DISMISSED AS MOOT

On August 24, 2012, relators filed a petition for writ of mandamus and a motion for 

emergency relief. This court granted the motion for emergency relief and requested a response 

which was timely filed. 

On September 28, 2012, relators filed an unopposed motion to dismiss the petition for 

writ of mandamus as moot, stating that actions taken by the probate court since the petition was 

filed disposed of the issues that formed the basis for the mandamus proceeding. The motion is

granted, and the petition for writ of mandamus and this original mandamus proceeding are 

dismissed as moot.

PER CURIAM

 1 This proceeding arises out of Cause No. 2007PC3281, styled Guardianship of A.M.P., An Incapacitated Person, 

pending in the Probate Court No. 1, Bexar County, Texas, the Honorable Polly Jackson Spencer presiding.
Unassociated Document









Exhibit 10.12


 


 







Amendment to Convertible Promissory note dated July 2, 2012 between Star Financial Corporation & Epazz, Inc.


 




 


Interest rate change: from no interest to an interest rate of 10%







 


 


 


 


The parties hereby indicate by their signatures below that they have read and agree with the modification to the promissory note.







Lender Information


Star Financial Corporation







Sign: /s/ Fay Passley


Fay Passley, President


July 2, 2012


 




 


Borrow Information


Epazz, Inc.


309 W. Washington St. Suite 1225


Chicago, IL 60606







Sign: /s/ Shaun Passley


Shaun Passley, CEO


July 2, 2012
Exhibit 32.1  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  In connection with the Annual Report of SINOCOM PHARMACEUTICAL, INC. (the "Company") on Form 10-K for the period ended December 31, 2009 (the "Report"), I, Xuexiang AI, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:  1) The Report fully complies with the requirement of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and  2) The information contained in the Report fairly presents, in all material respects, the Company's financial position and results of operations.      By: /s/ Xuexiang AI, CEO  Date:March 31, 2010
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the interim
condensed consolidated financial statements of Dental-Medical Diagnostic
Systems, Inc. as of the twelve months ended December 31, 1997 included in this
report on Form 10-KSB and is qualified in its entirety by reference to such
financial statements.
</LEGEND>
<RESTATED>
<CURRENCY>                                U.S. DOLLARS
       
<S>                                        <C>
<PERIOD-TYPE>                              12-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               DEC-31-1997
<EXCHANGE-RATE>                                      1
<CASH>                                       3,981,062
<SECURITIES>                                         0
<RECEIVABLES>                                1,967,614
<ALLOWANCES>                                    20,975
<INVENTORY>                                  2,896,270
<CURRENT-ASSETS>                             9,234,007
<PP&E>                                         748,985
<DEPRECIATION>                                 195,866
<TOTAL-ASSETS>                              10,492,026
<CURRENT-LIABILITIES>                        2,650,966
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        51,157
<OTHER-SE>                                   7,738,993
<TOTAL-LIABILITY-AND-EQUITY>                10,492,026
<SALES>                                     16,087,208
<TOTAL-REVENUES>                            16,087,208
<CGS>                                       10,234,206
<TOTAL-COSTS>                                7,501,082
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             138,576
<INCOME-PRETAX>                            (1,657,269)
<INCOME-TAX>                                   153,311
<INCOME-CONTINUING>                        (1,810,580)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                              (234,149)
<CHANGES>                                            0
<NET-INCOME>                               (2,044,729)
<EPS-PRIMARY>                                    (.47)
<EPS-DILUTED>                                    (.47)
        

</TABLE>
EXHIBIT 32.1

                   CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                              MARWICH II, LTD.
                    PURSUANT TO 18 U.S.D. SECTION 1350


In connection with the Annual Report of Marwich II, Ltd. (the "Company") on
Form 10-KSB for the fiscal year ended January 31, 2004, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I,
Peter Porath, Chief Executive Officer of the Company, certify, pursuant to
18 U.S.C. SS 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that to the best of my knowledge:

     (1)  The Report fully complies with the requirements of Section 13(a) or
15(d), as applicable, of the Securities Exchange Act of 1934; and

     (2)  The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.



/s/ Peter Porath
Peter Porath
Vice-President, Chief Executive Officer
November 15, 2004
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

      ( print page 66014)    
Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIHAI75N93023R00003: Pre-clinical Models of Infectious Diseases—Task Area A.                    

*Date:*                         October 20-27, 2023.                    

*Time:*                         10:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Rekha Dhanwani, Ph.D., Scientific Review Program, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, MSC 9834, Rockville, MD 20852, (240) 627-3076                         *rekha.dhanwani@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: September 20, 2023.

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2023-20876 Filed 9-25-23; 8:45 am]

BILLING CODE 4140-01-P
**Exhibit 15.1**

​

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

​

We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-253519 and 333-232693) of Genmab A/S of our report dated February 16, 2022 relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F.

/s/ PricewaterhouseCoopersStatsautoriseret RevisionspartnerselskabHellerup, DenmarkFebruary 16, 2022

----

​

PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab, CVR-nr. 33 77 12 31Strandvejen 44, DK-2900 Hellerup T: 3945 3945, www.pwc.dk

----